NASDAQ · NATR

Nature's Sunshine Products Inc.

$20.60 +$0.20 (+0.98%) 1D Market open

Key Metrics

$358.73M
Market cap
18.03×
P/E · TTM
$489.79M
Revenue · TTM
$19.89M
Net income
EPS · TTM $1.06
Dividend yield
Free cash flow $23.02M
Beta · 1Y 0.34
EBITDA · TTM $44.43M
Gross margin 72.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 4
    From its Mar 2 high, the share price fell 29%.

    Peak close $27.80 on Mar 2; trough close $19.68 on Jun 4. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -29%
  • May 11
    The stock moved -8.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$358.73M
Enterprise value
Shares outstanding17.6M
52-wk range$12.97 – $28.14
Avg volume · 20D68.5K
Net cash
Book value / share$8.86
IndustryPharmaceutical Preparations
ExchangeNASDAQ
About Nature's Sunshine Products Inc.
IPO dateAug 7, 1980
Employees806

Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E18.03
P/S0.73
P/FCF15.59
EV/EBITDA
EV/Sales
Graham №$14.50

Profitability

Gross 72.7%
Operating 6.3%
Net 4.1%
FCF 4.7%
ROE / ROIC 12.1% · 26.1%

Financial Health

Current ratio2.50
Quick ratio1.56
Debt / equity
Debt / EBITDA
Net cash
Working capital$107.22M

Cash Flow · TTM

Operating CF $30.87M
Capex −$7.85M
Free cash flow $23.02M
Buybacks $16.33M
Dividends paid
Shareholder yield 4.6%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

5.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$14.50 vs $20.60
Trades 1.4× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings